よむ、つかう、まなぶ。
資料２－２－４ 医療機器研究報告［1.8MB］ (143 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_53225.html |
| 出典情報 | 薬事審議会 医療機器・再生医療等製品安全対策部会（令和6年度第2回 3／6）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
医療機器研究報告
番号
医療機器の一般名
文献名
1422
経カテーテルブタ心のう膜弁
【The American Journal of Cardiology】Prosthesis Infolding Incidence And Short-Term Outcomes In TAVI Using
Evolut Self-Expandable Device: A Multicenter Study
1423
経カテーテルブタ心のう膜弁
【The American Journal of Cardiology】Prosthesis Infolding Incidence And Short-Term Outcomes In TAVI Using
Evolut Self-Expandable Device: A Multicenter Study
1424
経カテーテルブタ心のう膜弁
【The American Journal of Cardiology】Prosthesis Infolding Incidence And Short-Term Outcomes In TAVI Using
Evolut Self-Expandable Device: A Multicenter Study
1425
非吸収性ヘルニア・胸壁・腹壁用補綴材
【Acta Chirurgica Belgica, N/A, 2023】FIVE YEARS OF ROBOT-ASSISTED VENTRAL HERNIA REPAIR: INITIAL
EXPERIENCE AND SURGICAL OUTCOME
1426
吸収性ヘルニア・胸壁・腹壁用補綴材
【Acta Chirurgica Belgica, N/A, 2023】FIVE YEARS OF ROBOT-ASSISTED VENTRAL HERNIA REPAIR: INITIAL
EXPERIENCE AND SURGICAL OUTCOME
1427
心臓内補綴材
【HeartRhytm; January 19, 2024; DOI : https://doi.org/10.1016/j.hrthm.2024.01.018】Lower Rate of Major Bleeding in
Very High-Risk Patients Undergoing Left Atrial Appendage Occlusion: A Propensity-Matched Comparison with
Direct Oral Anticoagulation
1428
心臓内補綴材
【HeartRhytm; January 19, 2024; DOI : https://doi.org/10.1016/j.hrthm.2024.01.018】Lower Rate of Major Bleeding in
Very High-Risk Patients Undergoing Left Atrial Appendage Occlusion: A Propensity-Matched Comparison with
Direct Oral Anticoagulation
1429
心臓内補綴材
【Journal of Arrhythmia 2019: 35(Supplement 1) p.121】Meta-analysis comparing Amplatzar cardiac plug to Watchman
for stroke prevention in atrial fibrillation
1430
心臓内補綴材
【Journal of Arrhythmia 2019: 35(Supplement 1) p.218】The comparisons of safety and efficacy in using different
anticoagulants after left atrial appendage closure with watchman device
1431
心臓内補綴材
【Heart Lung and Circulation 2019: 28(Supplement 4) p.S385】Australian Experience with Left Atrial Appendage
Closure in Atrial Fibrillation Post Medicare Benefits Scheme (MBS) Approval
143 / 199
番号
医療機器の一般名
文献名
1422
経カテーテルブタ心のう膜弁
【The American Journal of Cardiology】Prosthesis Infolding Incidence And Short-Term Outcomes In TAVI Using
Evolut Self-Expandable Device: A Multicenter Study
1423
経カテーテルブタ心のう膜弁
【The American Journal of Cardiology】Prosthesis Infolding Incidence And Short-Term Outcomes In TAVI Using
Evolut Self-Expandable Device: A Multicenter Study
1424
経カテーテルブタ心のう膜弁
【The American Journal of Cardiology】Prosthesis Infolding Incidence And Short-Term Outcomes In TAVI Using
Evolut Self-Expandable Device: A Multicenter Study
1425
非吸収性ヘルニア・胸壁・腹壁用補綴材
【Acta Chirurgica Belgica, N/A, 2023】FIVE YEARS OF ROBOT-ASSISTED VENTRAL HERNIA REPAIR: INITIAL
EXPERIENCE AND SURGICAL OUTCOME
1426
吸収性ヘルニア・胸壁・腹壁用補綴材
【Acta Chirurgica Belgica, N/A, 2023】FIVE YEARS OF ROBOT-ASSISTED VENTRAL HERNIA REPAIR: INITIAL
EXPERIENCE AND SURGICAL OUTCOME
1427
心臓内補綴材
【HeartRhytm; January 19, 2024; DOI : https://doi.org/10.1016/j.hrthm.2024.01.018】Lower Rate of Major Bleeding in
Very High-Risk Patients Undergoing Left Atrial Appendage Occlusion: A Propensity-Matched Comparison with
Direct Oral Anticoagulation
1428
心臓内補綴材
【HeartRhytm; January 19, 2024; DOI : https://doi.org/10.1016/j.hrthm.2024.01.018】Lower Rate of Major Bleeding in
Very High-Risk Patients Undergoing Left Atrial Appendage Occlusion: A Propensity-Matched Comparison with
Direct Oral Anticoagulation
1429
心臓内補綴材
【Journal of Arrhythmia 2019: 35(Supplement 1) p.121】Meta-analysis comparing Amplatzar cardiac plug to Watchman
for stroke prevention in atrial fibrillation
1430
心臓内補綴材
【Journal of Arrhythmia 2019: 35(Supplement 1) p.218】The comparisons of safety and efficacy in using different
anticoagulants after left atrial appendage closure with watchman device
1431
心臓内補綴材
【Heart Lung and Circulation 2019: 28(Supplement 4) p.S385】Australian Experience with Left Atrial Appendage
Closure in Atrial Fibrillation Post Medicare Benefits Scheme (MBS) Approval
143 / 199